An In-Depth Comparative Analysis of Psychotherapy and Pharmacotherapy for Dissociative Identity Disorder

Abstract

Dissociative identity disorder is a complex disorder, and the symptoms include inconsistency in memory and personality identifications. It often co-occurs with other disorders, such as anxiety, depression and amnesia. To treat this disorder, two methods are being adopted: psychotherapy and pharmacotherapy. By comparing the past research and case studies, psychotherapy offered benefits such as reducing the risk of relapse and equipping patients with coping strategies. However, the challenges include long-term follow-up, patient motivation, and a relatively high dropout rate. Pharmacotherapy has demonstrated efficacy in treating dissociative identity disorder through medication. Nevertheless, the complexity of the disorder hinders the availability of precisely tailored medication. Moreover, potential side effects must be considered. A combination of psychotherapy and pharmacotherapy emerges as a promising avenue for more effective treatment by addressing both psychological and biological aspects of the disorder. Furthermore, it allows for personalized treatment plans, catering to individual needs and symptoms. Looking ahead, therapists should be more sensitive and empathetic toward the patients and exercise caution when delving into trauma histories. Therapists should also consider the adoption of a multidisciplinary approach to improve the lives of those affected by this complex disorder.